- Apr 23
- 3 min read
Recently, Medebound HEALTH has successfully signed a service contract with Taikang Insurance Group at its headquarter and Taikang Health Management Subsidiary. TaiKang Group is a Global Fortune 500 financial and insurance giant. In the contract, Medebound HEALTH will provide to its clients remote second opinion services from US top specialists. In the contract, the insurer prospects to promote Medebound’s remote second opinion services in all their 36 subsidiary companies nationwide.
About Taikang Group
Founded in 1996, Taikang Insurance Group is currently one of China’s largest insurance and financial services institutions. Taikang Insurance Group is an insurance and financial service conglomerate focused on insurance, asset management, and health and elderly care as main businesses. As a Global Fortune 500 list, the company has over RMB 1.5trillion in total assets under management and over 300 billion in retirement pensions, the company constitutes one of the largest corporate pension investors and management institutions in the Chinese market.
FAQ: Medebound HEALTH & Taikang Insurance Group Partnership
What is the new partnership between Medebound HEALTH and Taikang Insurance Group?
Recently, Medebound HEALTH signed a major service contract with Taikang Insurance Group at its headquarters, including Taikang Health Management Subsidiary.Under this agreement,
Medebound HEALTH will provide remote second opinion services from top U.S. specialists to Taikang’s clients.
Taikang plans to promote Medebound’s services across all 36 of its subsidiary companies nationwide, making U.S. expert medical guidance more accessible to millions of insured members.
Who is Taikang Insurance Group?
Taikang Group, founded in 1996, is one of China’s largest insurance and financial groups.Key facts:
A Global Fortune 500 company
Over RMB 1.5 trillion total assets under management
Over RMB 300 billion in retirement pensions
A leading institution in insurance, asset management, health care, and elderly care
Taikang is also one of China’s largest corporate pension investors and plays a significant role in the country’s health and longevity ecosystem.
What benefits does this partnership bring to Taikang clients?
Through this collaboration:
Taikang customers gain direct access to remote second opinions from top U.S. medical specialists, including experts from leading institutions like Mount Sinai, MD Anderson, and others.
Patients can receive diagnosis confirmation, treatment recommendations, and clinical trial insights without traveling abroad.
Medebound HEALTH will support patients through a secure, bilingual, and HIPAA-compliant platform.
This significantly enhances the medical services offered to Taikang’s nationwide client base.
How does Medebound HEALTH deliver remote second opinions?
Medebound HEALTH operates a proprietary bilingual tele-health platform designed for international patients.The platform provides:
Secure upload and translation of medical records
Transfer of imaging and test results to U.S. specialists
Video and written tele-consultations
Coordination of follow-up questions
Access to advanced medicines through a specialized pharmaceutical logistics network
This allows patients in Asia and other regions to consult U.S. specialists with just a few clicks.
Why do patients prefer using Medebound HEALTH for U.S. second opinions?
Key advantages include:
Access to top U.S. doctors across oncology, cardiology, rare diseases, and more
HIPAA-compliant, bilingual platform ideal for overseas patients
Fast turnaround, typically within 7–10 business days
Strong partnerships with major hospitals and insurance companies in Asia
Ability to access advanced medicines and clinical trial insights
Medebound HEALTH combines medical expertise, secure technology, and global logistics to offer a one-stop cross-border medical solution.
What types of diseases can be reviewed through Medebound HEALTH?
About China Curelink
China Curelink helps patients across Southeast Asia — including Indonesia, Malaysia, the Philippines, Vietnam, and Thailand — access the best cancer treatment at China's top hospitals, without the delays, language barriers, and administrative confusion that typically come with seeking care abroad.
We connect patients directly with China's top 5 cancer hospitals, ensuring that from the first case submission through to treatment and follow-up, every step is guided, translated, and coordinated by a team that understands both the medical and cultural needs of Southeast Asian patients.
China Curelink is proudly affiliated with Medebound HEALTH— an international medical concierge company headquartered in New York, specialized in securing premium second opinions from top US hospitals and specialists. With over 10 years of experience and more than 3,000 patients served worldwide, Medebound HEALTH is recognized as one of the leading patient access services across North America and the Asia Pacific, Medebound HEALTH brings the same standard of expert care coordination to every patient we serve.
This article is for informational purposes only and does not constitute medical advice. All treatment decisions should be made in consultation with a qualified oncologist who has reviewed your complete medical history and current diagnostic information.
Comments